Now showing items 2-21 of 637

      Title
      Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion [1]
      Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants [1]
      Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models [1]
      ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations [1]
      Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed. [1]
      Actively working to be more antiracist in the employee assistance field [1]
      Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data [1]
      Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations [1]
      Adapting clinical pharmacy staffing models during the COVID-19 pandemic: Lessons learned and considerations for future disaster planning [1]
      The additive impact of cardio-metabolic disorders and psychiatric illnesses on accelerated brain aging. [1]
      Addressing and Inspiring Vaccine Confidence in Black, Indigenous, and People of Color During the Coronavirus Disease 2019 Pandemic [1]
      Addressing challenges to rolling out COVID-19 vaccines in African countries [1]
      Addressing COVID-19 Vaccine Hesitancy in Patients with IBD [1]
      Addressing Racial Capitalism's Impact on Black Essential Workers During the COVID-19 Pandemic: Policy Recommendations. [1]
      Adenovirus-based vaccines - a platform for pandemic preparedness against emerging viral pathogens. [1]
      Adherence to personal protective equipment guidelines during the COVID-19 pandemic among healthcare personnel: A louisiana case study [1]
      Adjunctive nutraceutical therapies for COVID-19 [1]
      Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1–6 Days Compared to More than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen Flare [1]
      Advances in antiviral nucleoside analogues and their prodrugs [1]
      Aerosols Generated during Endodontic Treatment: A Special Concern during the Coronavirus Disease 2019 Pandemic [1]